Partnering

Among various types of molecular data, metabolomics provides the most functional information. We have pioneered an AI-driven technology that can characterize metabolite masses fast and inexpensively to expedite drug discovery and development.

Drug and Disease Mechanism

ReviveMed discovers detailed molecular pathways associated with a disease or a drug treatment.

Therapeutic Targets

We can reveal novel therapeutic targets by leveraging data from metabolites.

Drug Reprofiling

Using metabolomics, we identify new therapeutic effects for existing drugs or drugs in development.

Biomarker Discovery

We discover mechanistic-based biomarker signatures associated with a disease or a drug treatment from biofluid metabolomic data.

Please visit our Pipeline page to see how we can hack metabolic diseases using AI. 

To learn more about partnership opportunities, please email us at partnering@revivemed.io.